Handok (002390) - Total Liabilities
Based on the latest financial reports, Handok (002390) has total liabilities worth ₩512.43 Billion KRW (≈ $347.27 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Handok - Total Liabilities Trend (2011–2025)
This chart illustrates how Handok's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Handok's working capital to evaluate short-term liquidity relative to the company's equity base.
Handok Competitors by Total Liabilities
The table below lists competitors of Handok ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dongnam Chem
KO:023450
|
Korea | ₩50.03 Billion |
|
Groupe LDLC SA
PA:ALLDL
|
France | €164.91 Million |
|
Hyundai E P
KO:089470
|
Korea | ₩317.54 Billion |
|
NPC Co. Ltd
KO:004250
|
Korea | ₩175.92 Billion |
|
Big Ridge Gold Corp
V:BRAU
|
Canada | CA$986.91K |
|
RoboRobo Co. Ltd
KQ:215100
|
Korea | ₩2.10 Billion |
|
CENIT Aktiengesellschaft
XETRA:CSH
|
Germany | €112.46 Million |
|
Xin Chio Global Co Ltd
TWO:3171
|
Taiwan | NT$668.54 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Handok's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Handok market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Handok's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Handok (2011–2025)
The table below shows the annual total liabilities of Handok from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩512.43 Billion ≈ $347.27 Million |
+2.59% |
| 2024-12-31 | ₩499.49 Billion ≈ $338.50 Million |
+11.07% |
| 2023-12-31 | ₩449.71 Billion ≈ $304.76 Million |
-8.08% |
| 2022-12-31 | ₩489.25 Billion ≈ $331.56 Million |
+6.92% |
| 2021-12-31 | ₩457.57 Billion ≈ $310.09 Million |
+4.69% |
| 2020-12-31 | ₩437.08 Billion ≈ $296.20 Million |
+8.01% |
| 2019-12-31 | ₩404.67 Billion ≈ $274.24 Million |
+19.29% |
| 2018-12-31 | ₩339.24 Billion ≈ $229.90 Million |
-2.69% |
| 2017-12-31 | ₩348.63 Billion ≈ $236.26 Million |
+4.51% |
| 2016-12-31 | ₩333.60 Billion ≈ $226.08 Million |
+47.04% |
| 2015-12-31 | ₩226.88 Billion ≈ $153.75 Million |
+9.23% |
| 2014-12-31 | ₩207.71 Billion ≈ $140.76 Million |
+15.88% |
| 2013-12-31 | ₩179.25 Billion ≈ $121.48 Million |
+20.19% |
| 2012-12-31 | ₩149.14 Billion ≈ $101.07 Million |
+14.83% |
| 2011-12-31 | ₩129.88 Billion ≈ $88.02 Million |
-- |
About Handok
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more